AAS
MGRM

Ameritas Advisory Services’s Monogram Orthopaedics MGRM Stock Holding History

Ameritas Advisory Services’s Portfolio MGRM Stock Details MGRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-266
Closed -$769 – 2615
2025
Q2 		$769 Buy
+266
New +$717 ﹤0.01% 2656

Other funds holding MGRM

Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Ameritas Advisory Services's MGRM Position: Q3 2025 in Review

Ameritas Advisory Services sold out of Monogram Orthopaedics (MGRM) in Q3 2025, closing a stake of 266 shares — an estimated $769 sold.

Ameritas Advisory Services first reported a position in MGRM in Q2 2025 and held it in 1 quarter. The position peaked at $769 in Q2 2025. 63 funds tracked by Wall St. Rank hold MGRM as of Q3 2025.

  • Ameritas Advisory Services reported no remaining Monogram Orthopaedics position as of Q3 2025 after selling out during the quarter.
  • Ameritas Advisory Services sold 266 Monogram Orthopaedics shares in Q3 2025, an estimated $769.
  • Ameritas Advisory Services first reported a position in Monogram Orthopaedics in Q2 2025 and held it in 1 quarter.
  • Ameritas Advisory Services's Monogram Orthopaedics position peaked at $769 in Q2 2025.
  • 63 funds tracked by Wall St. Rank held Monogram Orthopaedics as of Q3 2025.

Based on Ameritas Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.